Converge Bio Secures $25 Million to Advance AI-Driven Drug Discovery
Converge Bio, an AI-powered drug discovery startup, has raised $25 million in a Series A funding round led by Bessemer Venture Partners, with participation from executives affiliated with Meta, OpenAI, and Wiz.
